Beacon Biosignals Integrates CleveMed, SleepView Under Unified Brand
The consolidation brings together CleveMed’s home sleep testing infrastructure and Beacon’s AI-driven brain monitoring technology to advance at-home sleep diagnostics.
The consolidation brings together CleveMed’s home sleep testing infrastructure and Beacon’s AI-driven brain monitoring technology to advance at-home sleep diagnostics.
With Philips Respironics discontinuing the Alice 6, Alice NightOne, and Alice PDx devices, where will sleep specialists turn for their sleep diagnostics equipment?
WatchPAT ONE and NightOwl ease cross-contamination worries and offer almost-immediate sleep apnea testing results. But they aren’t for everyone.
Read MoreHave you considered diagnosing and managing sleep apnea patients who live hours away by letting an HST vendor handle some of the work?
Read MoreDuring and after the pandemic, the road ahead for sleep labs is likely to look different than what has been traveled before.
Read MoreTelemedicine appointments and drop-shipped home sleep tests surge during the pandemic. Some predict these changes may be incorporated into a new normal.
Read MoreElectrode and sensor makers report more sample requests for their disposable options.
Read MoreLearn from sleep clinicians who have partnered with mail-order sleep study fulfillment providers about how to use such third-party services to your sleep lab’s advantage.
Read MoreVikas Jain, MD, FAASM, finds that HST can lower barriers to entry not only for patients, but for sleep specialists as well.
Read MoreThe vast majority of systems are siloed, but some companies are working to connect care for sleep...
Read MoreCleveMed, a home sleep testing (HST) device maker and fulfillment service provider, has achieved...
Read MoreTelemedicine encounters differ from being in the same room with patients —in surprising...
Read MoreAgile Medical, parent company of The CPAP Shop, has partnered with Welltrinsic, a subsidiary of...
Read MoreObstructive sleep apnea is a chronic condition, yet many clinicians and patients focus on the first 90 days. Some stakeholders envision years-long follow-up that considers the dynamic nature of the sleep disorder.
Read MoreCleveMed has been issued a new patent that covers the collection of patient data from standard home sensors and the data transfer using internet, cellular or wired-network methodologies, among others. US Patent number 10,028,698...
Read MoreCleveMed is offering a free pilot of its quarterly reporting service called “SleepView Insight.” SleepView Insight will provide customers with an analysis of their home sleep testing (HST) studies. Once requested by...
Read MoreCleveMed has been issued a new patent (US Patent No. 10,076,269) entitled “Devices and methods for sleep disorder diagnosis and treatment.” The patent covers technologies that enable data transfer from home sleep apnea therapy...
Read More